AC
MYOK

Athanor Capital’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Athanor Capital’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,558
Closed -$259K – 419
2019
Q4 		$259K Buy
+3,558
New +$216K 0.01% 327

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Athanor Capital's MYOK Position: Q1 2020 in Review

Athanor Capital sold out of MyoKardia, Inc. Common Stock (MYOK) in Q1 2020, closing a stake of 3,558 shares — an estimated $259K sold.

Athanor Capital first reported a position in MYOK in Q4 2019 and held it in 1 quarter. The position peaked at $259K in Q4 2019. 194 funds tracked by Wall St. Rank hold MYOK as of Q1 2020.

  • Athanor Capital reported no remaining MyoKardia, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Athanor Capital sold 3,558 MyoKardia, Inc. Common Stock shares in Q1 2020, an estimated $259K.
  • Athanor Capital first reported a position in MyoKardia, Inc. Common Stock in Q4 2019 and held it in 1 quarter.
  • Athanor Capital's MyoKardia, Inc. Common Stock position peaked at $259K in Q4 2019.
  • 194 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q1 2020.

Based on Athanor Capital's 13F filing for Q1 2020, filed 14 May 2020.